Early Increased Physical Activity, Cardiac Rehabilitation, and Survival After Implantable Cardioverter-Defibrillator Implantation

被引:5
|
作者
Atwater, Brett D. [1 ,2 ]
Li, Zhen [3 ]
Pritchard, Jessica [3 ]
Greiner, Melissa A. [3 ]
Nabutovsky, Yelena [4 ]
Hammill, Bradley G. [3 ]
机构
[1] Inova Heart & Vasc Inst, 3300 Gallows Rd, Fairfax, VA 22042 USA
[2] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC USA
[3] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA
[4] Abbott Vasc, Sunnyvale, CA USA
来源
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2021年 / 14卷 / 08期
关键词
cardiac rehabilitation; defibrillator; implantable; exercise; heart failure; mortality; CHRONIC HEART-FAILURE; EXERCISE; HOSPITALIZATION; ASSOCIATION; MORTALITY; ICD-9-CM; DISEASE; ALERTS; ADULTS; TIME;
D O I
10.1161/CIRCOUTCOMES.120.007580
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Increased physical activity (PA) through cardiac rehabilitation (CR) improves outcomes in patients with heart failure and coronary disease, but CR referral remains infrequent. Implantable cardioverter-defibrillators (ICDs) can provide daily PA measurements to patients that may motivate them to increase PA, but it remains unclear if increased ICD measured PA is associated with improved outcomes with and without CR. Methods: This is a retrospective observational study of 41 731 Medicare beneficiaries with ICD implantation between January 1, 2014 and December 31, 2016. We linked daily ICD PA measurements and Medicare claims data to determine if increased PA is associated with a reduction in the likelihood of death or heart failure hospitalization. To determine if CR participation altered the effect of PA on outcomes, we performed two additional analyses matching CR participants and nonparticipants using propensity scores. The first match included demographics, comorbidities, and baseline PA measurements. The second match also included the change in PA measured during CR or the same time frame after ICD implant among nonparticipants. Results: The mean age was 75 (SD, 10) years, 30 182 beneficiaries (72.3%) were male, and 1324 (3%) participated in CR. Increased ICD detected PA was associated with improved survival. CR participants had a mean PA change of +9.7 (SD, 57.8) min/d, whereas nonparticipants had a mean change of -1.0 (SD, 59.7) min/d (P<0.001). After matching for demographics, comorbidities and baseline PA, CR participants had significantly lower 1- to 3-year mortality (hazard ratio, 0.76 [95% CI, 0.69-0.85], P=0.03). After additionally matching for the ICD measured change in PA during CR there were no differences in mortality with and without CR (hazard ratio, 1.00 [95% CI, 0.82-1.21], P=0.87). Every 10 minutes of increased daily PA was associated with a 1.1% reduction in all-cause mortality in both groups. Conclusions: Among Medicare beneficiaries with ICDs, small increases in PA were associated with significant reductions in all-cause mortality.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] A Decision Tree-Based Survival Analysis of Patients with a History of Inappropriate Implantable Cardioverter-Defibrillator Therapy
    Yamamoto, Masaru
    Okajima, Katsunori
    Shimane, Akira
    Ozawa, Tomoya
    Morishima, Itsuro
    Asai, Toru
    Takagi, Masahiko
    Kasai, Atsunobu
    Fujii, Eitaro
    Kiyono, Ken
    Watanabe, Eiichi
    Ozaki, Yukio
    INTERNATIONAL HEART JOURNAL, 2019, 60 (02) : 318 - 326
  • [42] Survival in patients with heart failure and implantable cardioverter-defibrillator in an electrophysiological unit in Pereira, Colombia
    Arango-Franco, Ricardo
    Martinez, Jose-William
    Sosa-Urrea, Juan-David
    Marin-Medina, Daniel-Stiven
    Orozco-Hernandez, Juan-Pablo
    Martinez-Munoz, Manuel-Andres
    Henao-Martinez, Juan-Fernando
    Sanchez-Duque, Jorge-Andres
    ARCHIVOS DE MEDICINA, 2021, 21 (01): : 35 - 44
  • [43] Gender Differences in Implantable Cardioverter-Defibrillator Utilization for Primary Prevention of Sudden Cardiac Death
    Dahiya, Garima
    Chen, Jane
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2021, 23 (12)
  • [44] Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death
    Madhavan, Malini
    Waks, Jonathan W.
    Friedman, Paul A.
    Kramer, Daniel B.
    Buxton, Alfred E.
    Noseworthy, Peter A.
    Mehta, Ramila A.
    Hodge, David O.
    Higgins, Angela Y.
    Webster, Tracy L.
    Witt, Chance M.
    Cha, Yong-Mei
    Gersh, Bernard J.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2016, 9 (03)
  • [45] Reduction in electrocardiographic lateral precordial voltage after subcutaneous implantable cardioverter-defibrillator implantation
    Liang, Jackson J.
    Maeda, Shingo
    Supple, Gregory E.
    ACTA CARDIOLOGICA, 2017, 72 (02) : 221 - 222
  • [46] Timing of implantation of cardioverter-defibrillator after acute myocardial infarction
    Huikuri, Heikki V.
    EUROPACE, 2010, 12 (08): : 1057 - 1058
  • [47] Predicting long-term survival after de novo cardioverter-defibrillator implantation for primary prevention: A population based study
    Wang, Chang Nancy
    Lu, Zihang
    Simpson, Christopher S.
    Lee, Douglas S.
    Tranmer, Joan E.
    HELIYON, 2024, 10 (01)
  • [48] Comparative Effectiveness of Cardiac Resynchronization Therapy With an Implantable Cardioverter-Defibrillator Versus Defibrillator Therapy Alone
    Masoudi, Frederick A.
    Mi, Xiaojuan
    Curtis, Lesley H.
    Peterson, Pamela N.
    Curtis, Jeptha P.
    Fonarow, Gregg C.
    Hammill, Stephen C.
    Heidenreich, Paul A.
    Al-Khatib, Sana M.
    Piccini, Jonathan P.
    Qualls, Laura G.
    Hernandez, Adrian F.
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (09) : 603 - U148
  • [49] Time Course of Subsequent Shocks After Initial Implantable Cardioverter-Defibrillator Discharge and Implications for Driving Restrictions
    Merchant, Faisal M.
    Hoskins, Michael H.
    Benser, Michael E.
    Roberts, Gregory
    Bastek, Andrea N.
    Knezevic, Andrea
    Huang, Yijian
    Langberg, Jonathan J.
    Leon, Angel R.
    El-Chami, Mikhael F.
    JAMA CARDIOLOGY, 2016, 1 (02) : 181 - 188
  • [50] National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator
    Lindvall, Charlotta
    Chatterjee, Neal A.
    Chang, Yuchiao
    Chernack, Betty
    Jackson, Vicki A.
    Singh, Jagmeet P.
    Metlay, Joshua P.
    CIRCULATION, 2016, 133 (03) : 273 - 281